




Ronald J. Santilli is no longer serving in their position at Cutera, Inc.


























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology












See more news on Board and Executive Moves




        Ronald J. Santilli is no longer serving in their position at Cutera, Inc.    























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink



 

          Jul 14, 2017                         - RelSci Data Update                

          Board and Executive Moves      




Background Information:


Ronald J. Santilli »
Former Chief Executive, Financial & Accounting Officer at Cutera, Inc.


Career:




                                                                Cutera, Inc.                                                            







                                                                Lumenis Ltd.                                                            







                                                                Coherent, Inc.                                                            





Education:




                                                                San Jose State University                                                            







                                                                Golden Gate University - Edward S. Ageno School of Business                                                            







In The News:




                            Ronald J. Santilli has changed positions at Cutera, Inc.                            


                            July 13, 2017  •  RelSci                        





                            Cutera Announces Engagement of Sandy Gardiner as Consultant CFO                            


                            July 12, 2017  •  GlobeNewswire                        





                            Cutera, Inc. to Announce Results for the First Quarter Ended March 31, 2017                            


                            April 25, 2017  •  GlobeNewswire                        









Ronald J. Santilli »
Former Chief Executive, Financial & Accounting Officer at Cutera, Inc.






Career:

•


                                                                                    Cutera, Inc.                                                                                    



•


                                                                                    Lumenis Ltd.                                                                                    



•


                                                                                    Coherent, Inc.                                                                                    




Education:

•


                                                                                    San Jose State University                                                                                    



•


                                                                                    Golden Gate University - Edward S. Ageno School of Business                                                                                    







In The News:




 


                                                    Ronald J. Santilli has changed positions at Cutera, Inc.                                                





                                     July 13, 2017  •  RelSci                                





 


                                                    Cutera Announces Engagement of Sandy Gardiner as Consultant CFO                                                





                                     July 12, 2017  •  GlobeNewswire                                





 


                                                    Cutera, Inc. to Announce Results for the First Quarter Ended March 31, 2017                                                





                                     April 25, 2017  •  GlobeNewswire                                








Cutera, Inc. »
Cutera, Inc. engages in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. The company engages in sale of aesthetic medical equipment and services, and distribution of cosmeceutical and dermal filler products to qualified medical practitioners. Its products include Enlighten, Excel HR, Excel V, Xeo, and TruSculpt. The company was founded in August 1998 and is headquartered in Brisbane, CA.




In The News:




                            Global Tattoo Removal Market to Grow at a CAGR of 15.8% by 2021 - Key Vendors are Cutera, Cynosure, Lumenis & Syneron Medical - Research and Markets                            


                            May 19, 2017  •  Business Wire                        





                            Cutera announces launch of truSculpt 3D                            


                            May 16, 2017  •  Marketline Newswire                        





                            CUTERA Launches truSculptÂ® 3D €¦ A New Dimension in Body Sculpting                            


                            May 16, 2017  •  GlobeNewswire                        









Cutera, Inc. »
Cutera, Inc. engages in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. The company engages in sale of aesthetic medical equipment and services, and distribution of cosmeceutical and dermal filler products to qualified medical practitioners. Its products include Enlighten, Excel HR, Excel V, Xeo, and TruSculpt. The company was founded in August 1998 and is headquartered in Brisbane, CA.






In The News:




 


                                                    Global Tattoo Removal Market to Grow at a CAGR of 15.8% by 2021 - Key Vendors are Cutera, Cynosure, Lumenis & Syneron Medical - Research and Markets                                                





                                     May 19, 2017  •  Business Wire                                





 


                                                    Cutera announces launch of truSculpt 3D                                                





                                     May 16, 2017  •  Marketline Newswire                                





 


                                                    CUTERA Launches truSculptÂ® 3D €¦ A New Dimension in Body Sculpting                                                





                                     May 16, 2017  •  GlobeNewswire                                








See more news on Board and Executive Moves









You've found a premium RelSci Pro feature!



Connect to Individuals and Organizations In This Story

Upgrade to RelSci Pro to easily sync your contacts and see how you can reach the people and organizations featured in this article.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now










Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤













   Ronald Santilli | Cutera Inc | ZoomInfo.com


Cutera (NASDAQ:CUTR) Stock Price, News & Analysis | MarketBeat






















    























































































Cutera Company Profile (NASDAQ:CUTR)



  






Company Profile



Analyst Ratings



Earnings History



Earnings Estimates



Dividend History



Insider Trade



Headlines



Social Media



Chart






About Cutera (NASDAQ:CUTR)
Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. The Company also offers products, such as CoolGlide that includes CV, Excel and Vantage; Solera that includes Titan S, ProWave 770, OPS 600, LP560, AcuTip 500, Titan V/XL and LimeLight, and a third-party sourced system, myQ for the Japanese market. 


Industry, Sector and Symbol:

Sector: Computer and Technology
Industry: Laser Equipment
Sub-Industry: N/A
Symbol: NASDAQ:CUTR
CUSIP: N/A
Web: www.cutera.com

Capitalization:Market Cap: $368.64 millionOutstanding Shares: 13,858,000Average Prices:50 Day Moving Avg: $25.17200 Day Moving Avg: $21.3452 Week Range: $10.43 - $29.25


P/E:Trailing P/E Ratio: 103.07Foreward P/E Ratio: 38.99P/E Growth: 6.43Sales & Book Value:Annual Revenue: $124.93 millionPrice / Sales: 2.98Book Value: $4.27 per sharePrice / Book: 6.30


Profitability:EBIDTA: $4.14 millionNet Margins: 2.89%Return on Equity: 9.21%Return on Assets: 6.05%Debt:Current Ratio: 3.21%Quick Ratio: 2.61%Misc:Average Volume: 140,897 shs.Beta: 0.6Short Ratio: 1.76

 

Frequently Asked Questions for Cutera (NASDAQ:CUTR)
What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."



How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) issued its quarterly earnings results on Monday, May, 1st. The company reported ($0.07) earnings per share for the quarter, meeting the Zacks' consensus estimate of ($0.07). The business earned $29.30 million during the quarter, compared to the consensus estimate of $29 million. Cutera had a return on equity of 9.21% and a net margin of 2.89%. The business's quarterly revenue was up 30.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.16) EPS.  View Cutera's Earnings History.



When will Cutera make its next earnings announcement?

Cutera is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for Cutera.



What guidance has Cutera issued on next quarter's earnings?

Cutera issued an update on its FY17 earnings guidance on Monday, May, 1st. The company provided EPS guidance of $0.45-$0.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.76. The company issued revenue guidance of ~$140.0 million, compared to the consensus revenue estimate of $138.16 million.Cutera also updated its Q2 guidance to ~$0.03 EPS.



Where is Cutera's stock going? Where will Cutera's stock price be in 2017?

3 analysts have issued twelve-month target prices for Cutera's shares. Their predictions range from $32.00 to $33.00. On average, they anticipate Cutera's stock price to reach $32.33 in the next year. View Analyst Ratings for Cutera.



What are analysts saying about Cutera stock?

Here are some recent quotes from research analysts about Cutera stock: 
1. Maxim Group analysts commented, "At the Investor Day on 6/14/17, CUTR reiterated the 2Q17 and full-year 2017 guidance it originally introduced on May 1, 2017. During the Investor Day presentation, CUTR provided additional details on its five-year growth plan, highlighted by its projection of a tripling of its annual revenue to $360M in 2021, from $118M in 2016." (7/13/2017)
2. According to Zacks Investment Research, "Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system.   " (6/27/2017)




Who are some of Cutera's key competitors?

 Some companies that are related to Cutera include Forrester Research (FORR), Photronics (PLAB), Nanometrics Incorporated (NANO), Nova Measuring Instruments (NVMI), Axcelis Technologies (ACLS), CalAmp Corp. (CAMP), LivePerson (LPSN), QUANTENNA COMMS (QTNA), Perficient (PRFT), Unisys Corporation (UIS), FARO Technologies (FARO), Apptio (APTI), Everbridge (EVBG), Carbonite (CARB), Materialise NV (MTLS), Mistras Group (MG), PDF Solutions (PDFS) and Workiva (WK).



Who are Cutera's key executives?

Cutera's management team includes the folowing people: J. Daniel Plants, Chairman of the BoardJames A. Reinstein, President, Chief Executive Officer, DirectorDarren W. Alch, Vice President, General Counsel, SecretaryDavid B. Apfelberg M.D., Independent DirectorGregory A Barrett, Independent DirectorTimothy J. O'Shea, Independent DirectorClinton H. Severson, Independent DirectorJerry P. Widman CPA, Independent Director



Who owns Cutera stock?

Cutera's stock is owned by a number of of retail and institutional investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (1.32%), Summit Creek Advisors LLC (0.94%), Insight Capital Research & Management Inc. (0.22%) and Bank of Montreal Can (0.12%). Company insiders that own Cutera stock include David A Gollnick, J Daniel Plants, Jerry P Widman, Kevin P Connors, Larry Laber, Miguel Pardos and Ronald J Santilli. View Institutional Ownership Trends for Cutera.



Who sold Cutera stock? Who is selling Cutera stock?

Cutera's stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co.. Company insiders that have sold Cutera stock in the last year include David A Gollnick, J Daniel Plants, Larry Laber, Miguel Pardos and Ronald J Santilli. View Insider Buying and Selling for Cutera.



Who bought Cutera stock? Who is buying Cutera stock?

Cutera's stock was acquired by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Insight Capital Research & Management Inc. and Bank of Montreal Can.  View Insider Buying and Selling for Cutera.



How do I buy Cutera stock? 

Shares of Cutera can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. 



What is Cutera's stock price today?

One share of Cutera stock can currently be purchased for approximately $26.90.


MarketBeat Community Rating for Cutera (NASDAQ CUTR)Community Ranking:  2.8 out of 5 ( )Outperform Votes:  90 (Vote Outperform)Underperform Votes:  72 (Vote Underperform)Total Votes:  162MarketBeat's community ratings are surveys of what our community members think about Cutera and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.


Analyst Ratings
Consensus Ratings for Cutera (NASDAQ:CUTR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.Ratings Breakdown: 3 Buy RatingsConsensus Rating:Buy (Score: 3.00)Consensus Price Target: $32.33 (20.20% upside)

Analysts' Ratings History for Cutera (NASDAQ:CUTR)

Show:  
Only the Most Recent Rating From Each Brokerage
All Ratings For This Stock


DateFirmActionRatingPrice TargetImpact on Share PriceDetails7/13/2017Maxim GroupReiterated RatingBuy -> Buy$27.00 -> $33.00Low7/7/2017SidotiReiterated RatingBuy$30.00 -> $32.00Medium6/26/2017Roth CapitalInitiated CoverageBuy$32.00High(Data available from 7/22/2015 forward)


Earnings
Earnings History for Cutera (NASDAQ:CUTR)Earnings History by Quarter for Cutera (NASDAQ CUTR)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails7/31/2017        5/1/2017Q1 2017($0.07)($0.07)$29.00 million$29.30 millionViewListen2/13/2017Q4 2016$0.27$0.30$38.00 million$37.90 millionViewListen11/7/2016Q3$0.04$0.12$28.84 million$30.30 millionViewListen8/1/2016Q2($0.01)$0.07$26.20 million$27.50 millionViewListen5/2/2016Q1($0.12)($0.16)$21.62 million$22.40 millionViewListen2/8/2016Q4$0.11$0.25$29.59 million$30.00 millionViewListen11/2/2015Q315($0.12)($0.07)$21.87 million$23.10 millionViewListen8/5/2015Q215($0.13)($0.13)$21.41 million$22.56 millionViewListen5/7/2015Q115($0.13)($0.25)$18.70 million$19.07 millionViewListen2/5/2015Q414$0.08($0.01)$24.56 million$25.50 millionViewListen11/3/2014Q314($0.13)($0.18)$18.10 million$18.70 millionViewListen8/4/2014Q214($0.08)($0.19)$19.69 million$17.72 millionViewListen5/8/2014Q114($0.12)($0.26)$17.02 million$16.20 millionViewListen2/11/2014Q413($0.01)($0.02)$21.70 million$22.20 millionViewListen11/4/2013Q313($0.03)($0.11)$20.96 million$16.80 millionViewListen8/5/2013Q2 2013($0.02)($0.04)$21.70 million$149.60 millionViewListen5/6/2013Q1 2013($0.11)($0.15)$18.29 million$15.97 millionViewListen2/11/2013Q4 2012$0.02$0.08$22.07 million$22.50 millionViewListen11/5/2012Q312($0.11)($0.06)$18.87 million$19.40 millionViewN/A8/6/2012($0.10)($0.10)ViewN/A5/10/2012($0.26)($0.38)ViewN/A2/13/2012($0.08)($0.06)ViewN/A11/7/2011($0.16)($0.21)ViewN/A8/1/2011($0.20)($0.18)ViewN/A5/2/2011($0.15)($0.28)ViewN/A2/2/2011($0.12)($0.09)ViewN/A(Data available from 1/1/2011 forward)


Estimates
Earnings Estimates for Cutera (NASDAQ:CUTR)2017 EPS Consensus Estimate: $0.51QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20171($0.08)($0.08)($0.08)Q2 20171$0.01$0.01$0.01Q3 20171$0.14$0.14$0.14Q4 20171$0.44$0.44$0.44(Data provided by Zacks Investment Research)


Dividends
Dividend History for Cutera (NASDAQ:CUTR)No dividend announcements for this company have been tracked by MarketBeat.com


Insider Trades
Insider Trading and Institutional Ownership History for Cutera (NASDAQ:CUTR)Insider Ownership Percentage: 11.60%Institutional Ownership Percentage: 81.42%Insider Trades by Quarter for Cutera (NASDAQ:CUTR)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/28/2017Larry LaberEVPSell1,000$25.88$25,880.00  6/26/2017David A GollnickDirectorSell10,000$25.08$250,800.00  6/26/2017Larry LaberEVPSell500$25.50$12,750.00  6/12/2017Larry LaberEVPSell2,563$24.36$62,434.68  6/1/2017Larry LaberEVPSell957$22.95$21,963.15  6/1/2017Ronald J SantilliCFOSell3,857$22.95$88,518.15  5/25/2017Larry LaberEVPSell6,482$22.89$148,372.98  5/24/2017David A GollnickDirectorSell39,204$22.31$874,641.24  5/9/2017Ronald J SantilliCFOSell20,856$19.90$415,034.40  5/8/2017Ronald J SantilliCFOSell60,991$19.99$1,219,210.09  4/24/2017Larry LaberEVPSell6,824$20.66$140,983.84  4/20/2017Miguel PardosEVPSell5,000$21.00$105,000.00  4/19/2017Larry LaberEVPSell2,176$20.54$44,695.04  4/10/2017Miguel PardosEVPSell5,000$20.00$100,000.00  4/3/2017Miguel PardosEVPSell5,000$20.73$103,650.00  3/13/2017J Daniel PlantsDirectorSell250,000$20.25$5,062,500.00  3/3/2017David A GollnickDirectorSell25,000$20.40$510,000.00  2/21/2017Larry LaberEVPSell1,500$21.97$32,955.00  11/30/2016David A GollnickDirectorSell17,914$17.01$304,717.14  11/14/2016Ronald J SantilliCEOSell53,346$14.05$749,511.30  6/7/2016Kevin P ConnorsCEOSell21,606$10.29$222,325.74  6/2/2016Kevin P ConnorsCEOSell33,098$10.58$350,176.84  5/4/2016Kevin P ConnorsCEOSell65,296$11.37$742,415.52  5/3/2016Kevin P ConnorsCEOSell13,172$11.45$150,819.40  5/2/2016Kevin P ConnorsCEOSell42,123$11.32$476,832.36  3/4/2016Jerry P WidmanDirectorSell12,000$12.01$144,120.00  9/4/2015Ronald J. SantilliCFOSell31,599$15.00$473,985.00  8/18/2015Ronald J. SantilliCFOSell5,459$15.02$81,994.18  8/17/2015Ronald J SantilliCFOSell17,942$15.02$269,488.84  6/22/2015David A GollnickDirectorSell6,448$15.04$96,977.92  6/8/2015Jerry P WidmanDirectorSell10,000$14.95$149,500.00  6/3/2015David A GollnickDirectorSell12,212$15.00$183,180.00  6/3/2015Ronald J SantilliCFOSell31,752$14.99$475,962.48  6/2/2015David B ApfelbergDirectorSell10,000$14.99$149,900.00  6/2/2015Ronald J SantilliCFOSell4,192$15.00$62,880.00  6/1/2015David A GollnickDirectorSell15,406$15.00$231,090.00  6/1/2015Kevin P ConnorsCEOSell5,010$14.90$74,649.00  6/1/2015Ronald J SantilliCFOSell19,663$14.98$294,551.74  5/12/2015David B ApfelbergDirectorSell7,000$14.08$98,560.00  4/24/2015David A GollnickDirectorSell1,961$14.17$27,787.37  4/13/2015Kevin P ConnorsCEOSell33,596$13.41$450,522.36  3/30/2015Kevin P ConnorsCEOSell99,704$13.11$1,307,119.44  3/9/2015Jerry P WidmanDirectorSell7,000$13.12$91,840.00  3/2/2015Ronald J SantilliCFOSell63,700$13.35$850,395.00  2/24/2015Clinton SeversonDirectorBuy4,000$12.50$50,000.00  2/22/2013David B ApfelbergDirectorSell16,211$12.55$203,448.05  8/23/2012Timothy J OsheaDirectorSell2,700$7.47$20,169.00  8/21/2012Kevin P ConnorsCEOBuy12,000$7.29$87,480.00  (Data available from 1/1/2013 forward)


Headlines
Headline Trends for Cutera (NASDAQ:CUTR)


Latest Headlines for Cutera (NASDAQ:CUTR)


Source:


All Sources
Trusted Sources
MarketBeat.com
Bloomberg
MarketWatch
Motley Fool
NASDAQ
Reuters
Seeking Alpha
The Street
The Wall Street Journal
Yahoo Finance




DateHeadlineCutera, Inc. to Announce Results for the Second Quarter Ended June 30, 2017feeds.benzinga.com - July 20 at 6:27 PMMaxim Group Increases Cutera, Inc. (NASDAQ:CUTR) Price Target to $33.00www.americanbankingnews.com - July 13 at 9:02 AMCutera Announces Engagement of Sandy Gardiner as Consultant CFOfinance.yahoo.com - July 12 at 3:29 PMCutera, Inc. (CUTR) Receives Consensus Rating of "Buy" from Brokerageswww.americanbankingnews.com - July 12 at 9:29 AMCutera, Inc. (CUTR) Rating Reiterated by Sidotiwww.americanbankingnews.com - July 7 at 11:10 PMZacks: Cutera, Inc. (CUTR) Given $28.67 Average Target Price by Analystswww.americanbankingnews.com - July 6 at 10:35 PMCritical Review: Cutera (CUTR) and Lumenis (LMNS)www.americanbankingnews.com - July 6 at 4:30 PMLumenis (LMNS) and Cutera (NASDAQ:CUTR) Head-To-Head Reviewwww.americanbankingnews.com - July 3 at 4:43 PMThe Spectranetics Corporation (SPNC) vs. Cutera (CUTR) Financial Comparisonwww.americanbankingnews.com - July 1 at 7:52 AMCutera, Inc. (CUTR) EVP Sells $12,750.00 in Stockwww.americanbankingnews.com - June 28 at 10:40 PMLarry Laber Sells 1,000 Shares of Cutera, Inc. (CUTR) Stockwww.americanbankingnews.com - June 28 at 7:59 PMDavid A. Gollnick Sells 10,000 Shares of Cutera, Inc. (CUTR) Stockwww.americanbankingnews.com - June 28 at 7:40 PMCutera, Inc. (CUTR) Upgraded at Zacks Investment Researchwww.americanbankingnews.com - June 27 at 10:20 PMCutera, Inc. (CUTR) Cut to Hold at Zacks Investment Researchwww.americanbankingnews.com - June 26 at 10:04 PMCutera, Inc. (CUTR) Research Coverage Started at Roth Capitalwww.americanbankingnews.com - June 26 at 8:48 AMHead to Head Contrast: Lumenis (LMNS) vs. Cutera (CUTR)www.americanbankingnews.com - June 25 at 12:26 AMCutera, Inc. (CUTR) Stock Rating Upgraded by Zacks Investment Researchwww.americanbankingnews.com - June 20 at 9:14 PMComparing Lumenis (LMNS) & Cutera (CUTR)www.americanbankingnews.com - June 20 at 2:47 PMReviewing Lumenis (LMNS) & Cutera (CUTR)www.americanbankingnews.com - June 19 at 8:20 PMContrasting Cutera (CUTR) & Lumenis (LMNS)www.americanbankingnews.com - June 19 at 7:49 AM Cutera, Inc. (CUTR) Given Average Rating of "Strong Buy" by Analystswww.americanbankingnews.com - June 15 at 12:32 PMInsider Selling: Cutera, Inc. (CUTR) EVP Sells 2,563 Shares of Stockwww.americanbankingnews.com - June 13 at 10:32 PMCutera to Host Analyst & Investor Day on June 14, 2017finance.yahoo.com - June 8 at 9:51 AM Brokerages Expect Cutera, Inc. (CUTR) Will Announce Earnings of $0.03 Per Sharewww.americanbankingnews.com - June 6 at 9:26 AMCutera Names Darren W. Alch, Vice President, General Counsel and Secretaryfinance.yahoo.com - June 5 at 4:37 PMCutera, Inc. (CUTR) Given "Buy" Rating at Sidotiwww.americanbankingnews.com - June 3 at 10:40 PMCutera, Inc. (CUTR) EVP Sells $21,963.15 in Stockwww.americanbankingnews.com - June 2 at 10:33 PMCutera, Inc. (CUTR) CFO Ronald J. Santilli Sells 3,857 Shareswww.americanbankingnews.com - June 2 at 10:33 PMETFs with exposure to Cutera, Inc. : June 2, 2017finance.yahoo.com - June 2 at 6:04 PMLarry Laber Sells 6,482 Shares of Cutera, Inc. (CUTR) Stockwww.americanbankingnews.com - May 30 at 10:27 AMCutera, Inc. (CUTR) Director Sells $874,641.24 in Stockwww.americanbankingnews.com - May 26 at 7:41 PMCutera (CUTR) Shows Strength: Stock Adds 5.4% in Sessionfinance.yahoo.com - May 26 at 5:09 PMZacks: Brokerages Set $27.00 Price Target for Cutera, Inc. (CUTR)www.americanbankingnews.com - May 16 at 8:34 PMCUTERA Launches truSculpt® 3D … A New Dimension in Body Sculptingfinance.yahoo.com - May 16 at 12:12 PMRonald J. Santilli Sells 20,856 Shares of Cutera, Inc. (CUTR) Stockwww.americanbankingnews.com - May 10 at 11:22 PM$0.03 EPS Expected for Cutera, Inc. (CUTR) This Quarterwww.americanbankingnews.com - May 10 at 10:08 AMInsider Selling: Cutera, Inc. (CUTR) CFO Sells 60,991 Shares of Stockwww.americanbankingnews.com - May 8 at 7:17 PMCutera, Inc. (CUTR) Rating Lowered to Sell at Zacks Investment Researchwww.americanbankingnews.com - May 4 at 11:18 PMFY2018 EPS Estimates for Cutera, Inc. (CUTR) Lowered by Gabelliwww.americanbankingnews.com - May 4 at 7:10 PMETFs with exposure to Cutera, Inc. : May 4, 2017finance.yahoo.com - May 4 at 4:44 PMCutera, Inc. (CUTR) Downgraded by TheStreet to Cwww.americanbankingnews.com - May 3 at 5:56 PMSomewhat Positive News Coverage Likely to Affect Cutera (CUTR) Share Pricewww.americanbankingnews.com - May 3 at 3:04 PMCutera, Inc. :CUTR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017finance.yahoo.com - May 3 at 2:14 PMEdited Transcript of CUTR earnings conference call or presentation 1-May-17 9:00pm GMTfinance.yahoo.com - May 2 at 12:05 PMSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Cutera, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directorsfinance.yahoo.com - May 2 at 12:05 PMCutera, Inc. (CUTR) Announces  Earnings Resultswww.americanbankingnews.com - May 2 at 11:16 AMCutera, Inc. (CUTR) Releases Q2 Earnings Guidancewww.americanbankingnews.com - May 1 at 8:34 PMCutera, Inc. (CUTR) Releases FY17 Earnings Guidancewww.americanbankingnews.com - May 1 at 8:34 PMCutera reports 1Q lossmarketbeat.com - May 1 at 5:21 PMInvestor Network: Cutera, Inc. to Host Earnings Callfinance.yahoo.com - May 1 at 4:30 PM


Social





Chart
Cutera (CUTR) Chart for Saturday, July, 22, 2017




This page was last updated on 7/22/2017 by MarketBeat.com Staff












































﻿






























Cutera, Inc. (NASDAQ:CUTR) Stock Rating Upgraded by BidaskClub - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Cutera Inc.

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Cutera Inc. with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

ServisFirst Bancshares (SFBS) Earning Somewhat Positive Media Coverage, Report Finds
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact EchoStar Corporation (SATS) Share Price
Spirit Aerosystems Holdings (SPR) Receives News Impact Rating of 0.18
Positive Media Coverage Likely to Impact Schlumberger N.V. (SLB) Share Price
United Bank Inc. Lowers Stake in E.I. du Pont de Nemours and Company (NYSE:DD)
Cenovus Energy Inc (NYSE:CVE) Stock Rating Lowered by Morgan Stanley
Cushing Renaissance Fund (SZC) Earns Media Sentiment Score of 0.31
Sun Communities (SUI) Earns Media Sentiment Score of 0.16
Rowan Companies PLC (NYSE:RDC) Stake Boosted by BlackRock Inc.
RBC Bearings Incorporated (NASDAQ:ROLL) Position Raised by BlackRock Inc.
BlackRock Inc. Raises Stake in ESCO Technologies Inc. (NYSE:ESE)
BlackRock Inc. Has $180.92 Million Stake in Forward Air Corporation (NASDAQ:FWRD)
Innospec Inc. (NASDAQ:IOSP) Shares Sold by New York State Teachers Retirement System
New York State Teachers Retirement System Has $1,176,000 Position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)
OSI Systems, Inc. (NASDAQ:OSIS) Stake Maintained by New York State Teachers Retirement System
Clean Energy Fuels Corp. (NASDAQ:CLNE) Shares Sold by Renaissance Technologies LLC
California Public Employees Retirement System Acquires 14,000 Shares of Crocs, Inc. (NASDAQ:CROX)
Methanex Co. (MX) Receives “Sector Perform” Rating from Scotiabank
TIAA CREF Investment Management LLC Has $4.69 Million Stake in Quanex Building Products Corporation (NYSE:NX)
Nike, Inc. (NYSE:NKE) Shares Sold by Condor Capital Management







Cutera, Inc. (NASDAQ:CUTR) Stock Rating Upgraded by BidaskClub


					Posted by Lucas Kauffman on Jul 14th, 2017 // No Comments




Cutera, Inc. (NASDAQ:CUTR) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Wednesday.
Other equities research analysts also recently issued reports about the company. Sidoti  reiterated a “buy” rating and set a $30.00 target price (up from $27.00) on shares of Cutera in a report on Saturday, June 3rd. Zacks Investment Research downgraded Cutera from a “hold” rating to a “sell” rating in a report on Thursday, May 4th. TheStreet downgraded Cutera from a “b-” rating to a “c” rating in a report on Monday, May 1st. Finally, Roth Capital began coverage on Cutera in a report on Monday, June 26th. They set a “buy” rating and a $32.00 target price on the stock. Four investment analysts have rated the stock with a buy rating and one  has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $31.50.


 Get Cutera Inc. alerts:



Shares of Cutera (NASDAQ CUTR) traded down 0.37% during trading on Wednesday, hitting $26.85. The stock had a trading volume of 17,724 shares. The company has a market cap of $372.09 million, a P/E ratio of 102.87 and a beta of 0.60. The stock’s 50-day moving average price is $23.01 and its 200-day moving average price is $20.36. Cutera has a one year low of $10.43 and a one year high of $29.25. 





Cutera (NASDAQ:CUTR) last released its quarterly earnings data on Monday, May 1st. The medical device company reported ($0.07) EPS for the quarter, hitting analysts’ consensus estimates of ($0.07). The company had revenue of $29.30 million for the quarter, compared to the consensus estimate of $29 million. Cutera had a return on equity of 9.21% and a net margin of 2.89%. The company’s quarterly revenue was up 30.8% compared to the same quarter last year. During the same period last year, the business posted ($0.16) EPS.  On average, equities research analysts forecast that  Cutera will post $0.46 EPS for the current fiscal year. 
TRADEMARK VIOLATION NOTICE: “Cutera, Inc. (NASDAQ:CUTR) Stock Rating Upgraded by BidaskClub” was originally  posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.chaffeybreeze.com/2017/07/14/cutera-inc-nasdaqcutr-stock-rating-upgraded-by-bidaskclub.html. 
In other Cutera news, CFO Ronald J. Santilli sold 60,991 shares of Cutera stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $19.99, for a total transaction of $1,219,210.09. Following the sale, the chief financial officer now directly owns 174,025 shares in the company, valued at approximately $3,478,759.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Larry Laber sold 2,176 shares of Cutera stock in a transaction that occurred on Wednesday, April 19th. The stock was sold at an average price of $20.54, for a total value of $44,695.04. Following the sale, the executive vice president now owns 78,852 shares in the company, valued at $1,619,620.08. The disclosure for this sale can be found here. Insiders have sold a total of 160,410 shares of company stock worth $3,410,284 over the last 90 days. 11.60% of the stock is owned by company insiders. 
A number of large investors have recently bought and sold shares of CUTR. Russell Investments Group Ltd. acquired a new stake in  Cutera during the fourth quarter valued at about $321,000.  State Street Corp raised its position in shares of  Cutera by 1.9% in the fourth quarter. State Street Corp now owns 171,125 shares of the medical device company’s stock valued at $2,970,000 after buying an additional 3,191 shares during the last quarter.  Federated Investors Inc. PA raised its position in shares of  Cutera by 143.7% in the fourth quarter. Federated Investors Inc. PA now owns 12,568 shares of the medical device company’s stock valued at $218,000 after buying an additional 7,410 shares during the last quarter.  Two Sigma Investments LP raised its position in shares of  Cutera by 16.4% in the fourth quarter. Two Sigma Investments LP now owns 53,498 shares of the medical device company’s stock valued at $928,000 after buying an additional 7,519 shares during the last quarter.  Finally, Teachers Advisors LLC raised its position in shares of  Cutera by 56.0% in the fourth quarter. Teachers Advisors LLC now owns 38,794 shares of the medical device company’s stock valued at $673,000 after buying an additional 13,923 shares during the last quarter. Institutional investors own  81.33% of the company’s stock. 
Cutera Company Profile
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.






Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 


















































Cutera, Inc. (NASDAQ:CUTR) Upgraded to “Strong-Buy” at BidaskClub | Daily Political











































































Home
About/Contact
Columnists
Privacy Policy
























Headlines
Politics
Nation
World
Issues
Economy
Finance




















Cutera Inc. - Get News & Ratings Daily

		Enter your email address below to get the latest news and analysts' ratings for Cutera Inc. with our FREE daily email newsletter:



 






Follow DailyPolitical

 
 










Latest News



Gener8 Maritime Inc (NASDAQ:GNRT) Rating Lowered to Hold at BidaskClub					

Energizer Holdings, Inc. (NYSE:EPC) Rating Lowered to Strong Sell at BidaskClub					

Fitbit, Inc. (NYSE:FIT) Lowered to Strong Sell at BidaskClub					

DSP Group, Inc. (NASDAQ:DSPG) Raised to “Sell” at BidaskClub					

Cutera, Inc. (NASDAQ:CUTR) Upgraded to “Strong-Buy” at BidaskClub					

Lancashire Holdings Limited (LON:LRE) Coverage Initiated at Credit Suisse Group					

Barclays PLC Reaffirms “Underweight” Rating for Rolls-Royce Holding PLC (LON:RR)					

Q2 2017 EPS Estimates for United Rentals, Inc. (NYSE:URI) Boosted by Northcoast Research					

Equity BancShares Inc (NASDAQ:EQBK) Set to Announce Quarterly Earnings on Wednesday					

KCG Holdings, Inc. (NYSE:KCG) Set to Announce Quarterly Earnings on Wednesday					

Dover Corporation (NYSE:DOV) to Release Earnings on Wednesday					

Valmont Industries, Inc. (NYSE:VMI) Scheduled to Post Quarterly Earnings on Wednesday					

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Sees Large Decrease in Short Interest					

Extended Stay America, Inc. (STAY) Sees Significant Increase in Short Interest					

VEREIT Inc. (VER) Sees Large Increase in Short Interest					

Commerzbank Ag Analysts Give Wirecard AG (ETR:WDI) a €80.00 Price Target					

Volkswagen AG (ETR:VOW3) Given a €170.00 Price Target by BNP Paribas Analysts					

Software AG (ETR:SOW) Given a €45.00 Price Target at Baader Bank					

Goldman Sachs Group, Inc. (The) Analysts Give SAP SE (ETR:SAP) a €108.00 Price Target					

Norma Group SE (ETR:NOEJ) Given a €54.00 Price Target by Warburg Research Analysts					





 





						Cutera, Inc. (NASDAQ:CUTR) Upgraded to “Strong-Buy” at BidaskClub					

						 July 17th, 2017  - 0 comments - Filed Under -
 by Patrick Bannon 


							Filed Under: Analyst Articles - US - Finance 







Tweet










BidaskClub upgraded shares of Cutera, Inc. (NASDAQ:CUTR) from a buy rating to a strong-buy rating in a research note published on Wednesday morning.
A number of other brokerages have also recently weighed in on CUTR. Sidoti  reissued a buy rating and set a $32.00 price target (up from $30.00) on shares of Cutera in a research report on Friday, July 7th. Zacks Investment Research cut shares of Cutera from a buy rating to a hold rating in a research report on Monday, June 26th. Roth Capital began coverage on shares of Cutera in a research report on Monday, June 26th. They set a buy rating and a $32.00 price target on the stock. Finally, TheStreet cut shares of Cutera from a b- rating to a c rating in a research report on Monday, May 1st. Four research analysts have rated the stock with a buy rating and one  has assigned  a strong buy rating to the stock. The stock currently has an average rating of Buy and a consensus target price of $31.50.
Shares of Cutera (NASDAQ CUTR) opened at 27.00 on Wednesday. Cutera has a 12 month low of $10.43 and a 12 month high of $29.25. The firm has a market cap of $374.17 million, a P/E ratio of 103.45 and a beta of 0.60. The stock’s 50 day moving average price is $23.01 and its 200-day moving average price is $20.36. 




Cutera (NASDAQ:CUTR) last announced its quarterly earnings results on Monday, May 1st. The medical device company reported ($0.07) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.07). The company had revenue of $29.30 million for the quarter, compared to analysts’ expectations of $29 million. Cutera had a net margin of 2.89% and a return on equity of 9.21%. The business’s quarterly revenue was up 30.8% compared to the same quarter last year. During the same period last year, the firm posted ($0.16) earnings per share.  Equities research analysts anticipate that  Cutera will post $0.46 earnings per share for the current fiscal year. 
COPYRIGHT VIOLATION WARNING: “Cutera, Inc. (NASDAQ:CUTR) Upgraded to “Strong-Buy” at BidaskClub” was first  published by Daily Political and is owned by of Daily Political. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/07/17/cutera-inc-nasdaqcutr-upgraded-to-strong-buy-at-bidaskclub.html. 
In related news, CFO Ronald J. Santilli sold 20,856 shares of the business’s stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $19.90, for a total value of $415,034.40. Following the sale, the chief financial officer now directly owns 92,178 shares of the company’s stock, valued at approximately $1,834,342.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Ronald J. Santilli sold 60,991 shares of the business’s stock in a transaction on Monday, May 8th. The shares were sold at an average price of $19.99, for a total transaction of $1,219,210.09. Following the completion of the sale, the chief financial officer now directly owns 174,025 shares in the company, valued at $3,478,759.75. The disclosure for this sale can be found here. Insiders sold a total of 160,410 shares of company stock worth $3,410,284 over the last ninety days. 3.30% of the stock is currently owned by insiders. 
Large investors have recently bought and sold shares of the stock. American International Group Inc. boosted its stake in  Cutera by 7.0% in the first quarter. American International Group Inc. now owns 7,221 shares of the medical device company’s stock valued at $149,000 after buying an additional 475 shares in the last quarter.  Metropolitan Life Insurance Co. NY bought a new stake in  Cutera during the first quarter valued at approximately $202,000.  Federated Investors Inc. PA boosted its stake in  Cutera by 143.7% in the fourth quarter. Federated Investors Inc. PA now owns 12,568 shares of the medical device company’s stock valued at $218,000 after buying an additional 7,410 shares in the last quarter.  Trexquant Investment LP bought a new stake in  Cutera during the first quarter valued at approximately $267,000.  Finally, Russell Investments Group Ltd. bought a new stake in  Cutera during the fourth quarter valued at approximately $321,000. 81.42% of the stock is currently owned by institutional investors and hedge funds. 
Cutera Company Profile
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.





Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



 
















 Comment on this Post

Click here to cancel reply.



Name (required)

Mail (will not be published) (required)

Website






Wordpress Hashcash needs javascript to work, but your browser has javascript disabled. Your comment will be deleted!




Latest News




Jeff Sessions Spoke of Resigning After Tensions Increase with Trump





President Trump’s Tweets Complicate Already Complicated Week





World Leaders Very Critical of Paris Agreement Decision by Trump





Aide to President Trump Resigns With More Expected





Scud-Class Missile Launched by North Korea














			© DailyPolitical, LLC 2009-2017. All rights reserved. 


Privacy Policy |
			About | Columnists 
			| Contact 

































































Ronald J. Santilli - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Ronald J. Santilli
Employee at Cutera, Inc.


View Full Profile
Are you Ronald J. Santilli? Claim your profile


 


Sign up for Equilar Atlas and view Ronald J. Santilli's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Ronald J. Santilli's  network and community.
												FOLLOW changes in Ronald J. Santilli's employment and money-in-motion.
												CONNECT with Ronald J. Santilli through your network of contacts.
												








Ronald J. Santilli's Executive Work History


Current


Employee, 
Cutera, Inc.


Past
To view Ronald J. Santilli's complete executive work history, sign up now
Education


														 B.S., 
															San Jose State University


														 M.B.A., 
															Golden Gate University


Age
57

 
 


Ronald J. Santilli's Biography



Ronald J. Santilli has served as our CFO since September 2001. From August 15, 2016 to December 31, 2016, Mr. Santilli held the dual role of Interim CEO and CFO. Mr. Santilli has performed the role of EVP since April 2007 to present and prior to that he held the position of Vice President of Finance and Administration. Prior to joining Cutera, from April 2001 to August 2001, Mr. Santilli served as Senior Director of Financial Planning and Accounting at Lumenis, a manufacturer of medical lasers. From May 1982 to March 2001, Mr. Santilli held several positions at Coherent Inc., including Sales Operations Manager, Controller of the Medical Group ...
(Read More)

			Ronald J. Santilli has served as our CFO since September 2001. From August 15, 2016 to December 31, 2016, Mr. Santilli held the dual role of Interim CEO and CFO. Mr. Santilli has performed the role of EVP since April 2007 to present and prior to that he held the position of Vice President of Finance and Administration. Prior to joining Cutera, from April 2001 to August 2001, Mr. Santilli served as Senior Director of Financial Planning and Accounting at Lumenis, a manufacturer of medical lasers. From May 1982 to March 2001, Mr. Santilli held several positions at Coherent Inc., including Sales Operations Manager, Controller of the Medical Group and, most recently, Director of Finance and Administration. Mr. Santilli holds a B.S. in Business Administration from San Jose State University and an M.B.A. in Finance from Golden Gate University.
		
Source: Cutera, Inc. on 05/01/2017
		
	

 






Sign up for Equilar Atlas and view Ronald J. Santilli's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Ronald J. Santilli. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Ronald J. Santilli's  network and community.
												FOLLOW changes in Ronald J. Santilli's employment and money-in-motion.
												CONNECT with Ronald J. Santilli through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Ronald J. Santilli


















Ronald J. Santilli's Connections (20)





Sign up now to view Ronald J. Santilli's 20 connections »









Clinton H. Severson
Chairman of the Board and Chief Executive Officer, Abaxis, Inc.









David A. Gollnick
Dir. and Contractor, Cutera, Inc.









Gregory A. Barrett
Board Member, Cutera, Inc.









Kevin P. Connors
Former President, Chief Executive Officer and Director, Cutera, Inc.









David B. Apfelberg
Former Lead Independent Director, Cutera, Inc.









Michael J. Levernier
Former Vice President of Clinical Development, Cutera, Inc.









Larry E. Laber
Executive Vice President,  North America Sales, Cutera, Inc.









Guy P. Nohra
Former Board Member, KalVista Pharmaceuticals, Inc.









Timothy J. O'Shea
Former Board Member, Cutera, Inc.









John J. Connors
Former Executive Vice President of Worldwide Sales and Marketing, Cutera, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Jan Koum
Board Member, Facebook, Inc.









Philip L. Milstein
Board Member, The Marcus Corporation












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
























 


﻿
































Somewhat Positive Media Coverage Extremely Unlikely to Affect Cutera (NASDAQ:CUTR) Share Price - Markets Daily













































 
























 




 





















Daily Ratings & News for Cutera Inc.
        	Complete the form below to receive the latest headlines and analysts' recommendationsfor Cutera Inc. with our free daily email newsletter:



 





Follow @TheMarketsDaily


The Markets Daily









Recent Posts

Metaldyne Performance Group (NYSE:MPG) Earns Media Impact Rating of 0.46
Curis (NASDAQ:CRIS) Receives Daily Media Impact Rating of 0.25
Somewhat Positive Media Coverage Extremely Unlikely to Affect Cutera (NASDAQ:CUTR) Share Price
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Consolidated-Tomoka Land (NYSE:CTO) Share Price
Calamos Global Dynamic Income Fund (NASDAQ:CHW) Receives Daily Media Impact Score of 0.32
Reviewing IDEX Corporation (IEX) & Franklin Electric Co. (FELE)
Positive News Coverage Likely to Affect Armstrong World Industries (AWI) Stock Price
Amphenol Corporation (APH) versus Neonode (NEON) Financial Comparison
Head-To-Head Contrast: Ryanair Holdings PLC (RYAAY) versus Hawaiian Holdings (HA)
Tompkins Financial Corp Has $316,000 Stake in Fortive Corporation (FTV)
Atria Investments LLC Purchases 56 Shares of ExlService Holdings, Inc. (NASDAQ:EXLS)
GW&K Investment Management LLC Buys New Position in Four Corners Property Trust, Inc. (FCPT)
Winslow Evans & Crocker Inc. Raises Stake in Pembina Pipeline Corp. (PBA)
National Pension Service Increases Stake in Harris Corporation (HRS)
Eaton Vance Tax Managed Buy Write Opport (NYSE:ETV) Stake Raised by Winslow Evans & Crocker Inc.
Citizens Financial Group, Inc. (CFG) Shares Bought by Mn Services Vermogensbeheer B.V.
People’s Utah Bancorp (NASDAQ:PUB) Position Decreased by James Investment Research Inc.
James Investment Research Inc. Acquires New Position in M.D.C. Holdings, Inc. (NYSE:MDC)
Eqis Capital Management Inc. Raises Position in Arrow Electronics, Inc. (NYSE:ARW)
InterXion Holding N.V. (NYSE:INXN) Shares Bought by Eqis Capital Management Inc.




 


Somewhat Positive Media Coverage Extremely Unlikely to Affect Cutera (NASDAQ:CUTR) Share Price

					Posted by Tristan Rich on Jul 17th, 2017 // No Comments 




News coverage about Cutera (NASDAQ:CUTR) has trended somewhat positive this week, according to Accern. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Cutera earned a news impact score of 0.19 on Accern’s scale. Accern also assigned media stories about the medical device company an impact score of 10 out of 100, indicating that recent media coverage is extremely unlikely to have an impact on the stock’s share price in the near future. 
These are some of the news articles that may have effected Accern Sentiment’s scoring: 


 Get Cutera Inc. alerts:




The Shire PLC (NASDAQ:SHPG) Stock Rating Upgraded by HSBC Holdings plc (healthcaremenu.net)
Cutera, Inc. (NASDAQ:CUTR) Stock Traded Significantly Above Its 50 Day Moving Average (highlightpress.com)
Maxim Group Increases Cutera, Inc. (NASDAQ:CUTR) Price Target to $33.00 (americanbankingnews.com)
Cutera Announces Engagement of Sandy Gardiner as Consultant CFO (finance.yahoo.com)
Cutera, Inc. (CUTR) Receives Consensus Rating of “Buy” from Brokerages (americanbankingnews.com)

Several research analysts recently issued reports on CUTR shares. Sidoti started coverage on Cutera in a research report on Tuesday, April 11th. They set a “buy” rating and a $27.00 price objective for the company. Zacks Investment Research upgraded Cutera from a “sell” rating to a “buy” rating and set a $28.00 price objective for the company in a research report on Tuesday, June 20th. Roth Capital started coverage on Cutera in a research report on Monday, June 26th. They set a “buy” rating and a $32.00 price objective for the company. TheStreet downgraded Cutera from a “b-” rating to a “c” rating in a research report on Monday, May 1st. Finally, BidaskClub upgraded Cutera from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, July 12th. Four research analysts have rated the stock with a buy rating and one  has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $31.50.




Shares of Cutera (NASDAQ CUTR) opened at 27.00 on Monday. The firm has a 50-day moving average of $23.01 and a 200 day moving average of $20.36. The stock has a market capitalization of $374.17 million, a PE ratio of 103.45 and a beta of 0.60. Cutera has a 1-year low of $10.43 and a 1-year high of $29.25. 
Cutera (NASDAQ:CUTR) last issued its quarterly earnings results on Monday, May 1st. The medical device company reported ($0.07) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.07). The business had revenue of $29.30 million during the quarter, compared to the consensus estimate of $29 million. Cutera had a net margin of 2.89% and a return on equity of 9.21%. The firm’s quarterly revenue was up 30.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.16) EPS.  On average, equities analysts anticipate that  Cutera will post $0.46 earnings per share for the current fiscal year. 
In other Cutera news, EVP Larry Laber sold 2,176 shares of the stock in a transaction that occurred on Wednesday, April 19th. The shares were sold at an average price of $20.54, for a total value of $44,695.04. Following the completion of the sale, the executive vice president now owns 78,852 shares in the company, valued at approximately $1,619,620.08. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director David A. Gollnick sold 39,204 shares of the stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $22.31, for a total transaction of $874,641.24. Following the completion of the sale, the director now owns 34,136 shares of the company’s stock, valued at approximately $761,574.16. The disclosure for this sale can be found here. In the last 90 days, insiders sold 160,410 shares of company stock valued at $3,410,284. 3.30% of the stock is owned by insiders. 
ILLEGAL ACTIVITY WARNING: This piece of content was  published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.themarketsdaily.com/2017/07/17/somewhat-positive-media-coverage-extremely-unlikely-to-affect-cutera-nasdaqcutr-share-price.html. 
Cutera Company Profile
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.







Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



 





























Latest News






Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website


























































Ronald J. Santilli, CFO, VP - Finance, Administration, Cutera Inc.














A publisher of Business Information since 1983   
  





 


   

Search Business Search Executive 
  Advanced Search 




  

Sign In  |  Hints 









Profile of Ronald Santilli 





 


Ronald Santilli

 

CFO, VP - Finance, Administration - Cutera Inc.

 


Ronald Santilli Email :
Please login 

 

Company Name : 
Cutera Inc. 

 

Company Website : 
www.cutera.com 

 

Company Address : 
3240 Bayshore Blvd., Brisbane, CA,United States, 


 


Ronald Santilli Profile :
CFO, VP - Finance, Administration - Cutera Inc. 

 


Ronald Santilli Biography :


Ronald J. Santilli has served as our Chief Financial Officer and Vice President of Finance and Administration since September 2001. From April 2001 to August 2001, Mr. Santilli served as Senior Director of Financial Planning and Accounting at Lumenis, a manufacturer of medical lasers. From May 1993 to March 2001, Mr. Santilli held several positions at Coherent, including Sales Operations Manager, Controller of the Medical Group and, most recently, Director of Finance and Administration. Mr. Santilli holds a B.S. in Business Administration from San Jose State University and an M.B.A. in Finance from Golden Gate University. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements contained on Cutera's Investor Relations web pages which are not historical facts may be considered forward-looking statements, including, without limitation, statements as to trends, management's beliefs, expectations and opinions, which are based upon a number of assumptions concerning future conditions that ultimately may prove to be inaccurate. Such forward-looking statements are subject to risks and uncertainties and may be affected by various factors that may cause actual results to differ materially from those in the forward-looking statements. For further information that could cause actual results to differ from Cutera's expectations as well as other factors that could affect Cutera's financial statements, please refer to the Cutera's reports filed with the Securities and Exchange Commission. 

 


Ronald Santilli Colleagues :





Name 
Title 
Email 


Annette Campbell-White 
Board Dir. 
Please login 


David Apfelberg 
Board Dir. 
Please login 


Kevin Connors 
Board Dir., Pres., CEO 
Please login 


David Gollnick 
Dir., VP - Research, Development 
Please login 


Jerry Widman 
Board Dir. 
Please login 













            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory    





 

� 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.



